Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Aug 17, 2026, 4:00 PM EDT
2.210
-0.040 (-1.78%)
After-hours: Aug 17, 2026, 7:30 PM EDT
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $10.2 million as of August 17, 2026. Its market cap has decreased by -81.52% in one year.
Market Cap
10.20M
Enterprise Value
8.46M
1-Year Change
-81.52%
Ranking
Category
Stock Price
$2.25
ChartMarket Cap Chart
Since April 3, 2018, Lunai Bioworks's market cap has decreased from $198.90M to $10.20M, a decrease of -94.87%. That is a compound annual growth rate of -29.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 10.20M | -50.62% |
| Dec 31, 2025 | 20.66M | -84.42% |
| Dec 31, 2024 | 132.61M | -37.28% |
| Dec 29, 2023 | 211.43M | 287.68% |
| Dec 30, 2022 | 54.54M | -85.67% |
| Dec 31, 2021 | 380.68M | 176.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Instinct Bio Technical Company Holdings | 10.97M |
| Theriva Biologics | 10.90M |
| Vistagen Therapeutics | 10.60M |
| CytoMed Therapeutics | 10.41M |
| BioCardia | 10.30M |
| Adial Pharmaceuticals | 10.27M |
| GT Biopharma | 10.24M |
| Aspire Biopharma Holdings | 10.15M |